‘If they don’t help on Russian oil issue…’: Donald Trump’s new tariff warning to India; praises PM Modi

US President Donald Trump (AP photo) US President Donald Trump on Monday issued a fresh warning to India, reiterating that the US will raise tariffs on New Delhi “if they don’t help on Russian oil issue,” once again tying his threat to the Russia-Ukraine war and India’s alleged role in bolstering Moscow through continued crude…

Read More

Data shows legacy media took a more balanced view of bitcoin in 2025

Despite mainstream media coverage of crypto becoming more negative in recent years, a report found that in 2025, legacy media’s coverage of bitcoin became more balanced, with neutral reporting outweighing negative stories. According to an aggregate of sentiment data compiled by crypto intelligence platform Perception, the shift was less about enthusiasm for bitcoin and more…

Read More

Indore declares Bhagirathpura waterborne outbreak epidemic; calls in special teams to contain spread | India News

INDORE: The health administration in Indore on Sunday declared the waterborne disease outbreak in Bhagirathpura locality an epidemic, calling in specialised teams from the Central and state govts to contain the spread and identify the root cause of contamination that has claimed 10 lives so far in the area.Chief medical and health officer (CMHO) Dr…

Read More

5.1-magnitude earthquake jolts Assam: Tremors felt in Morigaon; no immediate damage reported | India News

NEW DELHI: An earthquake measuring 5.1 on the Richter Scale struck Morigaon district in Assam early Monday morning, the National Centre for Seismology (NCS) said. The tremor occurred at 04:17:40 IST, with its epicentre located at latitude 26.37 N and longitude 92.29 E, at a depth of 50 km. There were no immediate reports of…

Read More

‘Obesity therapy mkt set to evolve rapidly’

Danish firm Novo Nordisk expects India’s obesity therapy market to evolve rapidly, saying its recent Wegovy (injectable semaglutide) price cut could lift patient uptake five-to-seven-fold, echoing its insulin experience. This comes even as lower-priced generics loom, with a rival drugmaker, Eli Lilly & Co, also eyeing a share of one of the fastest-growing therapy segments.“Our…

Read More